683 Capital Management, LLC
NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$1.05B2026 Q3+ $1.36B options (notional, not included)
Positions151
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.54.6%
What Changed This Quarter?
Top Holdings
PLTRPUT
Palantir Technologies
18.9%
XBIPUT
SPDR Series
9.1%
LLYPUT
Eli Lilly
7.0%
NVDAPUT
NVIDIA
4.3%
ARKGPUT
Ark ETF Tr
3.8%
COF
Capital One Financial
2.9%
ABBVPUT
AbbVie
2.7%
CVNA
Carvana
2.1%
New / Increased
16 new · 30 increased
METANEW
Meta Platforms
1.7%
RVMDPUTNEW
Revolution Medicines
0.9%
WVENEW
Wave Life Sciences
0.8%
MBGLNEW
Mobility Global
0.7%
Rainier Acqui…NEW
Rainier Acquisition
0.4%
XBIPUT
SPDR Series
9.1%
+157.4%
ARKGPUT
Ark ETF Tr
3.8%
+126.7%
IOVAPUT
Iovance Biotherapeutics
1.3%
+216.7%
Reduced / Exited
26 reduced · 18 sold out
BBIO 2.5 03-15-27
Bridgebio Pharma
0.1%
-95.4%
TGTX
TG Therapeutics
0.4%
-56.1%
LLYPUT
Eli Lilly
7.0%
-5.2%
TRAX
First Tracks Biotherapeutics
0.9%
-20.0%
PTGX
Protagonist Therapeutics
1.5%
-12.1%
96663EUREXIT
Wave Life Sciences
1.4%
GOOGLEXIT
Alphabet
0.6%
BLDREXIT
Builders Firstsource
0.4%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.